Lima LM - Search Results

1

Thota S, Rodrigues DA, Pinheiro PSM, Lima LM, Fraga CAM, Barreiro EJ. Thota S, et al. Among authors: lima lm. Bioorg Med Chem Lett. 2018 Sep 15;28(17):2797-2806. doi: 10.1016/j.bmcl.2018.07.015. Epub 2018 Jul 9. Bioorg Med Chem Lett. 2018. PMID: 30006065 Review.

2

Synthesis and antiplatelet evaluation of novel aryl-sulfonamide derivatives, from natural safrole.

Lima LM, Ormelli CB, Brito FF, Miranda AL, Fraga CA, Barreiro EJ. Lima LM, et al. Pharm Acta Helv. 1999 Jun;73(6):281-92. doi: 10.1016/s0031-6865(99)00004-7. Pharm Acta Helv. 1999. PMID: 10443173

3

Synthesis and analgesic activity of novel N-acylarylhydrazones and isosters, derived from natural safrole.

Lima PC, Lima LM, da Silva KC, Léda PH, de Miranda AL, Fraga CA, Barreiro EJ. Lima PC, et al. Among authors: lima lm. Eur J Med Chem. 2000 Feb;35(2):187-203. doi: 10.1016/s0223-5234(00)00120-3. Eur J Med Chem. 2000. PMID: 10758281

4

Novel phthalimide derivatives, designed as leukotriene D(4) receptor antagonists.

Lima LM, de Brito FC, de Souza SD, Miranda AL, Rodrigues CR, Fraga CA, Barreiro EJ. Lima LM, et al. Bioorg Med Chem Lett. 2002 Jun 3;12(11):1533-5. doi: 10.1016/s0960-894x(02)00203-2. Bioorg Med Chem Lett. 2002. PMID: 12031336

5

Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues.

Lima LM, Castro P, Machado AL, Fraga CA, Lugnier C, de Moraes VL, Barreiro EJ. Lima LM, et al. Bioorg Med Chem. 2002 Sep;10(9):3067-73. doi: 10.1016/s0968-0896(02)00152-9. Bioorg Med Chem. 2002. PMID: 12110331

6

Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury.

Rocco PR, Momesso DP, Figueira RC, Ferreira HC, Cadete RA, Légora-Machado A, Koatz VL, Lima LM, Barreiro EJ, Zin WA. Rocco PR, et al. Among authors: lima lm. Eur Respir J. 2003 Jul;22(1):20-7. doi: 10.1183/09031936.03.00108603. Eur Respir J. 2003. PMID: 12882446 Free article. Clinical Trial.

7

Bioisosterism: a useful strategy for molecular modification and drug design.

Lima LM, Barreiro EJ. Lima LM, et al. Curr Med Chem. 2005;12(1):23-49. doi: 10.2174/0929867053363540. Curr Med Chem. 2005. PMID: 15638729 Review. No abstract available.

8

LASSBio-468: a new achiral thalidomide analogue which modulates TNF-alpha and NO production and inhibits endotoxic shock and arthritis in an animal model.

Alexandre-Moreira MS, Takiya CM, de Arruda LB, Pascarelli B, Gomes RN, Castro Faria Neto HC, Lima LM, Barreiro EJ. Alexandre-Moreira MS, et al. Among authors: lima lm. Int Immunopharmacol. 2005 Mar;5(3):485-94. doi: 10.1016/j.intimp.2004.10.017. Int Immunopharmacol. 2005. PMID: 15683845

9

Design, synthesis and antiinflammatory activity of novel phthalimide derivatives, structurally related to thalidomide.

Machado AL, Lima LM, Araújo JX Jr, Fraga CA, Koatz VL, Barreiro EJ. Machado AL, et al. Among authors: lima lm. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1169-72. doi: 10.1016/j.bmcl.2004.12.012. Bioorg Med Chem Lett. 2005. PMID: 15686935

10

Evaluating the prophylactic potential of the phtalimide derivative LASSBio 552 on allergen-evoked inflammation in rats.

Neves JS, Lima LM, Fraga CA, Barreiro EJ, Miranda AL, Diaz BL, Balduino A, Siqueira Rde A, e Silva PM, Martins MA. Neves JS, et al. Among authors: lima lm. Eur J Pharmacol. 2005 Mar 28;511(2-3):219-27. doi: 10.1016/j.ejphar.2005.02.011. Eur J Pharmacol. 2005. PMID: 15792791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

408 results

Search Page